Salim Syed
Stock Analyst at Mizuho Securities
(1.45)
# 3,550
Out of 4,598 analysts
1108
Total ratings
43%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Salim Syed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintained: Buy | $221 → $241 | $202.33 | +19.11% | 133 | Aug 3, 2026 | |
| INCY Incyte | Maintained: Buy | $121 → $137 | $119.44 | +14.70% | 8 | Aug 3, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $27 → $23 | $5.58 | +312.19% | 81 | Aug 3, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $100 → $118 | $75.32 | +56.66% | 146 | Jun 23, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $25 | $9.12 | +174.12% | 9 | Jun 23, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $97 | $26.80 | +261.94% | 4 | Jun 23, 2026 | |
| IOVA Iovance Biotherapeutics | Maintained: Buy | $10 | $4.33 | +130.95% | 5 | Jun 22, 2026 | |
| NKTX Nkarta | Maintained: Buy | $12 | $2.10 | +471.43% | 42 | Jun 22, 2026 | |
| AMGN Amgen | Maintained: Hold | $303 | $379.37 | -20.13% | 171 | Jun 21, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $96 | $80.38 | +19.43% | 107 | Jun 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $8.54 | +110.90% | 81 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 | $54.26 | +200.41% | 24 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $130.14 | +30.63% | 111 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $24.97 | +80.22% | 40 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.90 | +426.32% | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.01 | +299.00% | 3 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $62 | $57.25 | +8.30% | 17 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $43 | $19.25 | +123.38% | 8 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.53 | +216.21% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $27.73 | +62.28% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $49.62 | n/a | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $127.68 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $19.46 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $24.96 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $2.75 | n/a | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.44 | n/a | 73 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $9.58 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $59.96 | n/a | 1 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $25.05 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.1 | $10.03 | n/a | 1 | Jul 2, 2019 |
Biogen
Aug 3, 2026
Maintained: Buy
Price Target: $221 → $241
Current: $202.33
Upside: +19.11%
Incyte
Aug 3, 2026
Maintained: Buy
Price Target: $121 → $137
Current: $119.44
Upside: +14.70%
Wave Life Sciences
Aug 3, 2026
Maintained: Buy
Price Target: $27 → $23
Current: $5.58
Upside: +312.19%
Cytokinetics
Jun 23, 2026
Maintained: Buy
Price Target: $100 → $118
Current: $75.32
Upside: +56.66%
Kura Oncology
Jun 23, 2026
Maintained: Buy
Price Target: $25
Current: $9.12
Upside: +174.12%
Maze Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $97
Current: $26.80
Upside: +261.94%
Iovance Biotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $10
Current: $4.33
Upside: +130.95%
Nkarta
Jun 22, 2026
Maintained: Buy
Price Target: $12
Current: $2.10
Upside: +471.43%
Amgen
Jun 21, 2026
Maintained: Hold
Price Target: $303
Current: $379.37
Upside: -20.13%
BridgeBio Pharma
Jun 21, 2026
Maintained: Buy
Price Target: $96
Current: $80.38
Upside: +19.43%
Jun 18, 2026
Maintained: Buy
Price Target: $18
Current: $8.54
Upside: +110.90%
Jun 18, 2026
Maintained: Buy
Price Target: $163
Current: $54.26
Upside: +200.41%
Jun 12, 2026
Maintained: Buy
Price Target: $170
Current: $130.14
Upside: +30.63%
Jun 12, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $24.97
Upside: +80.22%
Jun 10, 2026
Maintained: Buy
Price Target: $10
Current: $1.90
Upside: +426.32%
Jun 10, 2026
Maintained: Buy
Price Target: $8
Current: $2.01
Upside: +299.00%
Jun 2, 2026
Maintained: Buy
Price Target: $45 → $62
Current: $57.25
Upside: +8.30%
Mar 30, 2026
Maintained: Buy
Price Target: $45 → $43
Current: $19.25
Upside: +123.38%
Nov 14, 2025
Maintained: Buy
Price Target: $8
Current: $2.53
Upside: +216.21%
Aug 18, 2025
Maintained: Buy
Price Target: $45
Current: $27.73
Upside: +62.28%
May 20, 2025
Maintained: Buy
Price Target: $85
Current: $49.62
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $127.68
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $19.46
Upside: n/a
May 28, 2024
Maintained: Buy
Price Target: $53
Current: $24.96
Upside: n/a
Mar 25, 2024
Maintained: Buy
Price Target: $25
Current: $2.75
Upside: n/a
Jun 16, 2023
Rated: Hold
Price Target: n/a
Current: $1.44
Upside: n/a
Mar 6, 2023
Maintained: Buy
Price Target: $21
Current: $9.58
Upside: n/a
Nov 3, 2022
Maintained: Buy
Price Target: $23
Current: $59.96
Upside: n/a
Aug 4, 2022
Maintained: Buy
Price Target: $25
Current: $25.05
Upside: n/a
Jul 2, 2019
Maintained: Buy
Price Target: $7.1
Current: $10.03
Upside: n/a